142 related articles for article (PubMed ID: 22584327)
1. [Laryngeal preservation for hypopharyngeal cancer by radiotherapy with S-1 and vitamin A(TAR therapy)].
Nakashima T; Toh S; Shiratsuchi H; Yasumatsu R; Fukushima J; Nakamura K; Shioyama Y; Komune S
Gan To Kagaku Ryoho; 2012 May; 39(5):759-63. PubMed ID: 22584327
[TBL] [Abstract][Full Text] [Related]
2. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer.
Tai SK; Yang MH; Wang LW; Tsai TL; Chu PY; Wang YF; Huang JL; Chang SY
Jpn J Clin Oncol; 2008 Aug; 38(8):521-7. PubMed ID: 18697758
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of concomitant therapy with S-1, CDGP, and radiation for laryngeal cancer].
Morimoto M; Takemura H; Yui T; Suzuki T; Sanbe T; Suzaki H
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1903-6. PubMed ID: 20948253
[TBL] [Abstract][Full Text] [Related]
4. [Phase I study of concurrent radiotherapy with TS-1 and vitamin A (TAR Therapy) for head and neck cancer].
Nakashima T; Kuratomi Y; Yamamoto T; Masuda M; Hirakawa N; Nakamura K; Shioyama Y; Umezaki T; Komune S
Gan To Kagaku Ryoho; 2005 Jun; 32(6):803-7. PubMed ID: 15984520
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of concurrent chemoradiotherapy with S-1 plus nedaplatin for hypopharyngeal cancer].
Kobayashi S; Shimane T; Egawa S; Ono T; Mori T; Kamakazu K; Sanbe T
Gan To Kagaku Ryoho; 2011 Feb; 38(2):233-5. PubMed ID: 21368486
[TBL] [Abstract][Full Text] [Related]
6. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
[TBL] [Abstract][Full Text] [Related]
7. Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents.
Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
Acta Otolaryngol; 2013 Mar; 133(3):318-26. PubMed ID: 23153059
[TBL] [Abstract][Full Text] [Related]
8. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.
Zelefsky MJ; Kraus DH; Pfister DG; Raben A; Shah JP; Strong EW; Spiro RH; Bosl GJ; Harrison LB
Head Neck; 1996; 18(5):405-11. PubMed ID: 8864731
[TBL] [Abstract][Full Text] [Related]
9. [Laryngeal cancer treatment outcomes in our department].
Egawa S; Shimane T; Akiyama R; Ikenoya Y; Uzuki A; Sugimoto A; Hayashi T; Ikeda K; Sanbe T
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1301-5. PubMed ID: 21829068
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of concomitant therapy with S-1, nedaplatin, and radiation for laryngeal cancer].
Shimane T; Mori T; Ono T; Kaburagi A; Monden T; Furuya A; Kamakazu K; Kobayashi S; Sanbe T; Suzaki H
Gan To Kagaku Ryoho; 2010 Feb; 37(2):241-4. PubMed ID: 20154477
[TBL] [Abstract][Full Text] [Related]
11. [Radiotherapy combined with S-1 and cisplatin for locally advanced and metastatic esophageal cancer].
Iwase H
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():224-9. PubMed ID: 16898007
[TBL] [Abstract][Full Text] [Related]
12. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
13. Definitive radiotherapy for T1-2 hypopharyngeal cancer: a single-institution experience.
Nakajima A; Nishiyama K; Morimoto M; Nakamura S; Suzuki O; Kawaguchi Y; Miyagi K; Fujii T; Yoshino K
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e129-35. PubMed ID: 21640496
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy.
Chen SW; Yang SN; Liang JA; Lin FJ; Tsai MH
Head Neck; 2009 Jun; 31(6):709-16. PubMed ID: 19260114
[TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.
Altundag O; Gullu I; Altundag K; Yalcin S; Ozyar E; Cengiz M; Akyol F; Yucel T; Hosal S; Sozeri B
Head Neck; 2005 Jan; 27(1):15-21. PubMed ID: 15515158
[TBL] [Abstract][Full Text] [Related]
16. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J
J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck.
Tahara M; Minami H; Kawashima M; Kawada K; Mukai H; Sakuraba M; Matsuura K; Ogino T; Hayashi R; Ohtsu A
Cancer Sci; 2011 Feb; 102(2):419-24. PubMed ID: 21134076
[TBL] [Abstract][Full Text] [Related]
18. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
Lee NY; O'Meara W; Chan K; Della-Bianca C; Mechalakos JG; Zhung J; Wolden SL; Narayana A; Kraus D; Shah JP; Pfister DG
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):459-68. PubMed ID: 17493769
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservation.
Nishimura G; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Kawakami M; Watanabe M; Niho T; Abo H; Yamomoto S
Anticancer Res; 2009 Feb; 29(2):661-6. PubMed ID: 19331217
[TBL] [Abstract][Full Text] [Related]
20. Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial.
Urba SG; Moon J; Giri PG; Adelstein DJ; Hanna E; Yoo GH; Leblanc M; Ensley JF; Schuller DE
J Clin Oncol; 2005 Jan; 23(1):88-95. PubMed ID: 15625363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
